Case Report: Kidney allograft recovery after conversion to belatacept-based immunosuppression in simultaneous heart-kidney transplantation. (PubMed, Front Immunol) - Oct 3, 2026 - "At 6 months, both grafts are functioning, serum creatinine is 1.4 mg/dL and no DSA rebound occurred. This case highlights the potential role of belatacept-based immunosuppression in the complex setting of SHKT with prolonged kidney allograft dysfunction."
Journal • Antibody-mediated Rejection • Cardiovascular • Congestive Heart Failure • Genetic Disorders • Heart Failure • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Nephrology • Reperfusion Injury • Systemic Lupus Erythematosus • Transplant Rejection • Transplantation
|
|
Angelodaniele Napoletano; Chiara Baldovini; Daniele Vetrano; Elisa Gessaroli; Gaetano La Manna; Giorgia Comai; Luciano Potena; Mario Sabatino; Valeria Corradetti; Valeria Grandinetti; Vasilika Samara
|